Viewing Study NCT03836157

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:51 PM

Ignite Modification Date: 2026-01-05 @ 6:23 PM

Study NCT ID: NCT03836157

Status: WITHDRAWN

Last Update Posted: 2019-06-27

First Post: 2019-02-07

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Sponsor: University of Oklahoma

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module